Advanced Resin Therapeutics is a specialty pharmaceutical company (formerly Jaleva Pharmaceuticals, LLC) that has developed a novel, resin-based, drug delivery system that promotes topical and transmucosal delivery of medications more efficiently and effectively than current technologies.  The mechanism of action has been delineated in the laboratory on a molecular level, and the company has grown its IP portfolio to include 11 issued patents worldwide and 17 pending patents.  Clinical trial results confirm quick, safe, and prolonged delivery of medications for both its topical and transmucosal product lines.

ART’s lead product opportunity is NicoSwab™, a fast-acting, long-lasting nicotine replacement product (NRT) that outperforms competitive market leaders in pre-clinical and phase 1 clinical trials.

See Patented Resin Technologies for more details.